Devonian Health Group Inc.
DVHGF
$0.07
-$0.11-60.50%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -25.85% | 18.62% | 207.93% | 472.81% | 619.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.85% | 18.62% | 207.93% | 472.81% | 619.70% |
| Cost of Revenue | -27.99% | 23.19% | 198.52% | 522.67% | 673.34% |
| Gross Profit | -22.17% | 11.38% | 225.99% | 398.02% | 542.90% |
| SG&A Expenses | -15.83% | 4.90% | 62.58% | 68.10% | 108.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.78% | 1.45% | 0.45% | 1.47% | 2.86% |
| Total Operating Expenses | -20.33% | 18.73% | 132.18% | 214.55% | 239.56% |
| Operating Income | -216.76% | -22.16% | 137.42% | 120.38% | 85.67% |
| Income Before Tax | -615.87% | -438.69% | -15.23% | 112.48% | 78.81% |
| Income Tax Expenses | -51.93% | -51.93% | 264.05% | -- | -- |
| Earnings from Continuing Operations | -289.18% | -214.08% | -34.74% | 83.22% | 58.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -289.18% | -214.08% | -34.74% | 83.22% | 58.51% |
| EBIT | -216.76% | -22.16% | 137.42% | 120.38% | 85.67% |
| EBITDA | -686.78% | -63.97% | 156.83% | 132.32% | 94.76% |
| EPS Basic | -277.91% | -211.96% | -34.10% | 83.93% | 61.26% |
| Normalized Basic EPS | -67.86% | 25.00% | 129.00% | 111.43% | 79.86% |
| EPS Diluted | -228.28% | -170.75% | -24.06% | 84.87% | 58.40% |
| Normalized Diluted EPS | -74.07% | 22.58% | 129.29% | 112.14% | 80.58% |
| Average Basic Shares Outstanding | 3.41% | 0.82% | 0.96% | 3.66% | 5.93% |
| Average Diluted Shares Outstanding | 3.03% | 0.49% | 0.63% | 6.06% | 8.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |